Urokinase 750000IU Injection
Marketer
TTK Healthcare Ltd
Salt Composition
Urokinase (750000IU)
Overview Urokinase 750000IU Injection
Urokinase 750000IU Injection dissolves dangerous blood clots obstructing blood vessels. This medication treats patients recovering from a recent myocardial infarction. It also finds application in managing pulmonary embolism and stroke. Administration requires strict medical oversight; dosage and treatment length are determined individually by your physician, who will monitor your progress until stabilization. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk is also possible. Prior to administration, your doctor will thoroughly discuss the benefits and potential drawbacks. Continue all prescribed long-term medications alongside this injection. Caution is advised for patients with bleeding disorders, hepatic or renal impairment. Inform your physician of any such conditions, pregnancy, breastfeeding, or other medications you are currently using.
Primary Ingredients of Urokinase 750000IU Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Urokinase 750000IU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Urokinase 750000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Urokinase 750000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Urokinase 750000IU Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
How Urokinase 750000IU Injection works:
Urokinase 750000IU Injection breaks down dangerous blood clots within blood vessels. This action re-establishes blood circulation to compromised tissue, mitigating tissue damage and enhancing patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Urokinase 750000IU Injection lacks established safety data. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The administration of 750,000 IU Urokinase injections is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful consequences to fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Urokinase 750000 IU Injection without significant risk to their infants. Available data from human studies indicates minimal danger to the baby.
DrivingNOT RELEVANT
Inappropriate for outpatient settings; Urokinase 750000IU Injection is reserved for inpatients.
KidneySAFE IF PRESCRIBED
Administering 750,000 IU of Urokinase injection appears to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary in such cases, however, professional medical advice is crucial. Urokinase 750,000 IU injection is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver conditions should use Urokinase 750000IU Injection cautiously, as dose modification may be necessary. Medical advice is recommended.
What if you forget to take Urokinase 750000IU Injection :
Should you forget a dose of Urokinase 750000IU Injection, seek your physician's advice.
Facts to Know About Urokinase 750000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently